Medgend Icon

Ledgend of Medicine







discontinued


Valsartan FDA Approved Drugs

AMLODIPINE BESYLATE AND VALSARTAN [Amlodipine BesylateC20H25ClN2O5C6H6O3S : ValsartanC24H29N5O3]
RX
-
eq 10mg base : 160mg (oral tablet)
eq 10mg base : 320mg (oral tablet)
eq 5mg base : 160mg (oral tablet)
eq 5mg base : 320mg (oral tablet)
Alembic Pharms LtdApr 3, 2015
Aurobindo Pharma LtdApr 22, 2016
Invagen PharmsSep 16, 2016
LupinMar 30, 2015
Mylan Pharms IncMar 30, 2015
Novel Labs IncMar 30, 2015
Par Pharm IncMar 28, 2013
Teva Pharms UsaMar 30, 2015
Torrent Pharms LtdMar 30, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE [Amlodipine BesylateC20H25ClN2O5C6H6O3S : HydrochlorothiazideC7H8ClN3O4S2 : ValsartanC24H29N5O3]
RX
-
10mg : 12.5mg : 160mg (oral tablet)
10mg : 25mg : 160mg (oral tablet)
10mg : 25mg : 320mg (oral tablet)
5mg : 12.5mg : 160mg (oral tablet)
5mg : 25mg : 160mg (oral tablet)
Lupin LtdJun 3, 2015
Par PharmJun 1, 2015
Teva PharmsSep 25, 2012
Torrent Pharms LtdJun 3, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

BYVALSON [Nebivolol HydrochlorideC22H25F2NO4ClH : ValsartanC24H29N5O3]
RX
-
eq 5mg base : 80mg (oral tablet)
Forest Labs LlcJun 3, 2016
  • Method of treating hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIOVAN [ValsartanC24H29N5O3]
RX
-
160mg (oral tablet)
320mg (oral tablet)
40mg (oral tablet)
80mg (oral tablet)
NovartisJul 18, 2001
  • Treatment of hypertension.
  • Use of valsartan to reduce cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIOVAN HCT [HydrochlorothiazideC7H8ClN3O4S2 : ValsartanC24H29N5O3]
RX
-
12.5mg : 160mg (oral tablet)
12.5mg : 320mg (oral tablet)
12.5mg : 80mg (oral tablet)
25mg : 160mg (oral tablet)
25mg : 320mg (oral tablet)
NovartisMar 6, 1998
  • Treatment of hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ENTRESTO [SacubitrilC24H29NO5 : ValsartanC24H29N5O3]
RX
-
24mg : 26mg (oral tablet)
49mg : 51mg (oral tablet)
97mg : 103mg (oral tablet)
Novartis Pharms CorpJul 7, 2015
  • Treatment of heart failure.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EXFORGE [Amlodipine BesylateC20H25ClN2O5C6H6O3S : ValsartanC24H29N5O3]
RX
-
eq 10mg base : 160mg (oral tablet)
eq 10mg base : 320mg (oral tablet)
eq 5mg base : 160mg (oral tablet)
eq 5mg base : 320mg (oral tablet)
NovartisJun 20, 2007
  • Treatment of hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EXFORGE HCT [Amlodipine BesylateC20H25ClN2O5C6H6O3S : HydrochlorothiazideC7H8ClN3O4S2 : ValsartanC24H29N5O3]
RX
-
10mg : 12.5mg : 160mg (oral tablet)
10mg : 25mg : 160mg (oral tablet)
10mg : 25mg : 320mg (oral tablet)
5mg : 12.5mg : 160mg (oral tablet)
5mg : 25mg : 160mg (oral tablet)
NovartisApr 30, 2009
  • Treatment of hypertension.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VALSARTAN [ValsartanC24H29N5O3]
RX
-
160mg (oral tablet)
320mg (oral tablet)
Alembic Pharms LtdJan 5, 2015
Amneal PharmsJan 11, 2016
Aurobindo Pharma LtdJan 5, 2015
Hetero Labs Ltd VJan 5, 2015
Ivax PharmsJan 4, 2016
Jubilant GenericsJan 5, 2015
Lupin LtdJan 5, 2015
Macleods Pharms LtdSep 16, 2016
Mylan Pharms IncJan 5, 2015
Ohm Labs IncJun 26, 2014
Prinston IncJun 9, 2015
Torrent Pharms LtdJan 5, 2015
Watson Labs IncJan 5, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.